Steve Duffy

Most Recent Articles by Steve Duffy

How the Government Shutdown Affects FDA Activities

How the Government Shutdown Affects FDA Activities

By

The consequence of the shutdown means the budget appropriated by Congress for the Agency is on hold, resulting in ~7000 of it's 17,000 employees being furloughed.

TNFi Treatment Patterns Examined Among Pregnant Women

TNFi Treatment Patterns Examined Among Pregnant Women

By

Using a validated claims-based algorithm, study authors identified pregnancies among women 15-54 years of age from the US Sentinel System between January 1 2004 and September 30 2015.

Ixekizumab Compared With Adalimumab in Head-to-Head PsA Study

Ixekizumab Compared With Adalimumab in Head-to-Head PsA Study

By

The SPIRIT H2H trial (N=566) randomized PsA patients to receive ixekizumab (160mg starting dose followed by 80mg every 4 weeks) or adalimumab (40mg every 2 weeks) for 52 weeks.

FDA: E-Liquids Found to Contain Undeclared Prescription Drugs

FDA: E-Liquids Found to Contain Undeclared Prescription Drugs

By

Sildenafil and tadalafil can interact with nitrates found in some prescription drugs, such as nitroglycerin, and may lower blood pressure to dangerous levels.

Oral JAK/SYK Inhibitor Granted Fast Track Designation for Atopic Dermatitis

Oral JAK/SYK Inhibitor Granted Fast Track Designation for Atopic Dermatitis

By

The Food and Drug Administration (FDA) has granted Fast Track designation to the investigational oral dual inhibitor, ASN002 (Asana BioSciences), for the treatment of moderate-to-severe atopic dermatitis.

More Articles by Steve Duffy

Sign up for Newsletters